Eureka Prize: Prof. David Komander and the hope for new therapies against Parkinson's and cancer

At his laboratory in Melbourne, biochemist Prof. David Komander is researching how cells keep order with the help of the tiny protein ubiquitin. A key protein in this process is the PINK1 enzyme. The team's work lays the foundation for future drugs against diseases such as cancer or Parkinson's disease.

Das für den Eureka-Preis nominierte PINK1 Parkinson's Disease Research Team des WEHI. Von rechts nach links: Dr Alisa Glukhova, Dr Nicholas Kirk, Dr Sylvie Callegari, Professor David Komander. Credit: WEHI

For more stories, interviews, and news from SBS German, explore our podcast collection here.